Elizabeth A. Swanson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elizabeth A. Swanson has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Mitchell B. Sally
Department of Surgery, Division of Trauma, Critical Care and Acute Care Surgery, Oregon Health & Science University, Portland, OR, USA
4 shared publications Claus U. Niemann
Department of Anesthesia and Perioperative Care, University of California San Francisco, San Francisco, CA; Department of Surgery, University of California San Francisco, San Francisco, CA
3 shared publicationsDarren J. Malinoski
Department of Surgery, Division of Trauma, Critical Care and Acute Care Surgery, Oregon Health & Science University, Portland, OR, USA
3 shared publications- Darren Malinoski
Department of Surgery, Division of Trauma, Critical Care, and Acute Care Surgery, Oregon Health and Science University, Portland, Oregon
3 shared publications Kyle H. Sheetz
Center for Healthcare Outcomes & Policy, Institute of Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan; Department of Surgery, Michigan Medicine, University of Michigan, Ann Arbor, Michigan
3 shared publicationsMadhukar S. Patel
Department of Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada
3 shared publications
Latest Publications
- Open Access
- 29 June 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 325, 564-569
Association Between Daytime Liver Transplantation and Hospital Length of Stay and Graft and Patient Survival
- 29 June 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 325, 564-569
Open AccessAssociation Between Daytime Liver Transplantation and Hospital Length of Stay and Graft and Patient Survival
- 21 May 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (11) , 2557-2567
Kidney safety net utilization after liver transplant for acute alcohol-associated hepatitis
- 21 May 2026
- Published by Elsevier in American Journal of Transplantation
- Vol. 26 (11) , 2557-2567
Kidney safety net utilization after liver transplant for acute alcohol-associated hepatitis
- 9 May 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 323, 203
Response Regarding: Incisional Hernia After Liver Transplant: A Population-Level Retrospective Cohort Analysis
- 9 May 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 323, 203
Response Regarding: Incisional Hernia After Liver Transplant: A Population-Level Retrospective Cohort Analysis
- Open Access
- 19 March 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 321, 78-83
Incisional Hernia After Liver Transplant: A Population-Level Retrospective Cohort Analysis
- 19 March 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 321, 78-83
Open AccessIncisional Hernia After Liver Transplant: A Population-Level Retrospective Cohort Analysis
- 27 February 2025
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
Optimization of physiology in organ donors in the intensive care unit - what you need to know
Optimizing the physiology of organ donors is a critical component of preserving the option for organ donation and addressing the shortage of organs available for transplantation. In this article, we review common physiologic alterations seen in organ donors with a focus on brain-dead organ donors. These physiologic alterations and recommended interventions to optimize the physiology of the brain-dead organ donor are discussed by organ system, providing a framework for trauma surgeons and intensivists involved in the care of organ donors.
- 27 February 2025
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
Optimization of physiology in organ donors in the intensive care unit - what you need to know
Optimizing the physiology of organ donors is a critical component of preserving the option for organ donation and addressing the shortage of organs available for transplantation. In this article, we review common physiologic alterations seen in organ donors with a focus on brain-dead organ donors. These physiologic alterations and recommended interventions to optimize the physiology of the brain-dead organ donor are discussed by organ system, providing a framework for trauma surgeons and intensivists involved in the care of organ donors.
- Open Access
- 16 July 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (11) , 2108-2120
Development of an improved Scientific Registry of Transplant Recipients deceased donor heart yield model using donor critical care data from the Donor Management Goal Registry cohort
- 16 July 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (11) , 2108-2120
Open AccessDevelopment of an improved Scientific Registry of Transplant Recipients deceased donor heart yield model using donor critical care data from the Donor Management Goal Registry cohort
- Open Access
- 15 June 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (12) , 4003-4011
Critical care and ventilatory management of deceased organ donors impact lung use and recipient graft survival
- 15 June 2021
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (12) , 4003-4011
Open AccessCritical care and ventilatory management of deceased organ donors impact lung use and recipient graft survival
- 17 June 2020
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 231 (3) , 351-360e5
Impact of Deceased Donor Management on Donor Heart Use and Recipient Graft Survival
Current risk-adjusted models used to predict donor heart use and cardiac graft survival from organ donors after brain death (DBDs) do not include bedside critical care data. We sought to identify novel independent predictors of heart use and graft survival to better understand the relationship between donor management and transplantation outcomes. We conducted a prospective observational study of DBDs managed from 2008 to 2013 by 10 organ procurement organizations. Demographic data, critical care parameters, and treatments were recorded at 3 standardized time points during donor management. The primary outcomes measures were donor heart use and cardiac graft survival. From 3,433 DBDs, 1,134 hearts (33%) were transplanted and 969 cardiac grafts (85%) survived after 684 ± 392 days of follow-up. After multivariable analysis, independent positive predictors of heart use included standard criteria donor status (odds ratio [OR] 3.93), male sex (OR 1.68), ejection fraction > 50% (OR 1.64), and partial pressure of oxygen to fraction of inspired oxygen ratio > 300 (OR 1.31). Independent negative predictors of heart use included donor age (OR 0.94), BMI > 30 kg/m2 (OR 0.78), serum creatinine (OR 0.83), and use of thyroid hormone (OR 0.78). As for graft survival, after controlling for known recipient risk factors, thyroid hormone dose was the only independent predictor (OR 1.04 per μg/h). Modifiable critical care parameters and treatments predict donor heart use and cardiac graft survival. The discordant relationship between thyroid hormone and donor heart use (negative predictor) vs cardiac graft survival (positive predictor) warrants additional investigation.
- 17 June 2020
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 231 (3) , 351-360e5
Impact of Deceased Donor Management on Donor Heart Use and Recipient Graft Survival
Current risk-adjusted models used to predict donor heart use and cardiac graft survival from organ donors after brain death (DBDs) do not include bedside critical care data. We sought to identify novel independent predictors of heart use and graft survival to better understand the relationship between donor management and transplantation outcomes. We conducted a prospective observational study of DBDs managed from 2008 to 2013 by 10 organ procurement organizations. Demographic data, critical care parameters, and treatments were recorded at 3 standardized time points during donor management. The primary outcomes measures were donor heart use and cardiac graft survival. From 3,433 DBDs, 1,134 hearts (33%) were transplanted and 969 cardiac grafts (85%) survived after 684 ± 392 days of follow-up. After multivariable analysis, independent positive predictors of heart use included standard criteria donor status (odds ratio [OR] 3.93), male sex (OR 1.68), ejection fraction > 50% (OR 1.64), and partial pressure of oxygen to fraction of inspired oxygen ratio > 300 (OR 1.31). Independent negative predictors of heart use included donor age (OR 0.94), BMI > 30 kg/m2 (OR 0.78), serum creatinine (OR 0.83), and use of thyroid hormone (OR 0.78). As for graft survival, after controlling for known recipient risk factors, thyroid hormone dose was the only independent predictor (OR 1.04 per μg/h). Modifiable critical care parameters and treatments predict donor heart use and cardiac graft survival. The discordant relationship between thyroid hormone and donor heart use (negative predictor) vs cardiac graft survival (positive predictor) warrants additional investigation.
- 1 June 2020
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 88 (6) , 783-788
Vasopressor selection during critical care management of brain dead organ donors and the effects on kidney graft function
BACKGROUND: Delayed graft function (DGF), the need for dialysis in the first week following kidney transplant, affects approximately one quarter of deceased-donor kidney transplant recipients. Donor demographics, donor serum creatinine, and graft cold ischemia time are associated with DGF. However, there is no consensus on the optimal management of hemodynamic instability in organ donors after brain death (DBDs). Our objective was to determine the relationship between vasopressor selection during donor management and the development of DGF. METHODS: Prospective observational data, including demographic and critical care parameters, were collected for all DBDs managed by 17 organ procurement organizations from nine Organ Procurement and Transplantation Network Regions between 2012 and 2018. Recipient outcome data were linked with donor data through donor identification numbers. Donor critical care parameters, including type of vasopressor and doses, were recorded at three standardized time points during donor management. The analysis included only donors who received at least one vasopressor at all three time points. Vasopressor doses were converted to norepinephrine equivalent doses and analyzed as continuous variables. Univariate analyses were conducted to determine the association between donor variables and DGF. Results were adjusted for known predictors of DGF using binary logistic regression. RESULTS: Complete data were available for 5,554 kidney transplant recipients and 2,985 DBDs. On univariate analysis, donor serum creatinine, donor age, donor subtype, kidney donor profile index, graft cold ischemia time, phenylephrine dose, and dopamine dose were associated with DGF. After multivariable analysis, increased donor serum creatinine, donor age, kidney donor profile index, graft cold ischemia time, and phenylephrine dose remained independent predictors of DGF. CONCLUSION: Higher doses of phenylephrine were an independent predictor of DGF. With the exception of phenylephrine, the selection and dose of vasopressor during donor management did not predict the development of DGF. LEVEL OF EVIDENCE: Prognostic study, Level III.
- 1 June 2020
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 88 (6) , 783-788
Vasopressor selection during critical care management of brain dead organ donors and the effects on kidney graft function
BACKGROUND: Delayed graft function (DGF), the need for dialysis in the first week following kidney transplant, affects approximately one quarter of deceased-donor kidney transplant recipients. Donor demographics, donor serum creatinine, and graft cold ischemia time are associated with DGF. However, there is no consensus on the optimal management of hemodynamic instability in organ donors after brain death (DBDs). Our objective was to determine the relationship between vasopressor selection during donor management and the development of DGF. METHODS: Prospective observational data, including demographic and critical care parameters, were collected for all DBDs managed by 17 organ procurement organizations from nine Organ Procurement and Transplantation Network Regions between 2012 and 2018. Recipient outcome data were linked with donor data through donor identification numbers. Donor critical care parameters, including type of vasopressor and doses, were recorded at three standardized time points during donor management. The analysis included only donors who received at least one vasopressor at all three time points. Vasopressor doses were converted to norepinephrine equivalent doses and analyzed as continuous variables. Univariate analyses were conducted to determine the association between donor variables and DGF. Results were adjusted for known predictors of DGF using binary logistic regression. RESULTS: Complete data were available for 5,554 kidney transplant recipients and 2,985 DBDs. On univariate analysis, donor serum creatinine, donor age, donor subtype, kidney donor profile index, graft cold ischemia time, phenylephrine dose, and dopamine dose were associated with DGF. After multivariable analysis, increased donor serum creatinine, donor age, kidney donor profile index, graft cold ischemia time, and phenylephrine dose remained independent predictors of DGF. CONCLUSION: Higher doses of phenylephrine were an independent predictor of DGF. With the exception of phenylephrine, the selection and dose of vasopressor during donor management did not predict the development of DGF. LEVEL OF EVIDENCE: Prognostic study, Level III.
- Open Access
- 6 January 2020
- Published by Wiley in Physiological Reports
- Vol. 8 (1) , e14316
Tacrolimus‐induced hypomagnesemia and hypercalciuria requires FKBP12 suggesting a role for calcineurin
We showed that deletion of the tacrolimus‐binding protein, necessary for tacrolimus to inhibit calcineurin, completely prevented the effects on divalent ion metabolism. This was associated with prote...
- 6 January 2020
- Published by Wiley in Physiological Reports
- Vol. 8 (1) , e14316
Open AccessTacrolimus‐induced hypomagnesemia and hypercalciuria requires FKBP12 suggesting a role for calcineurin
We showed that deletion of the tacrolimus‐binding protein, necessary for tacrolimus to inhibit calcineurin, completely prevented the effects on divalent ion metabolism. This was associated with prote...